Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer.

导出 OA

翻译打印收藏纠错

作者： Y,Okugawa ^[1] ; C,Miki ; Y,Toiyama ; H,Yasuda ; T,Yokoe ; S,Saigusa ; J,Hiro ; K,Tanaka ; Y,Inoue ; M,Kusunoki

作者单位： Division of Reparative Medicine, Department of Gastrointestinal and Pediatric Surgery, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan. ^[1]

主题词碱基序列(Base Sequence);结直肠肿瘤(Colorectal Neoplasms);DNA引物(DNA Primers);疾病恶化(Disease Progression);女(雌)性(Female);HT29细胞(HT29 Cells);人类(Humans);免疫组织化学(Immunohistochemistry);男(雄)性(Male);受体, 白细胞介素6(Receptors, Interleukin-6)

DOI 10.1038/sj.bjc.6605827

PMID 20823887

发布时间 2021-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览15

British journal of cancer

2010年103卷6期

787-95页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer.

British journal of cancer

相似文献

British journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer.

British journal of cancer

相似文献

British journal of cancer

相关期刊

检索历史清除